Back to search

France· FR:60183061

NephroMAG 0,2 mg, trousse pour préparation radiopharmaceutique

A medicinal product containing mercaptoacétyltriglycine, registered in France by ROTOP PHARMAKA (ALLEMAGNE).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNephroMAG 0,2 mg, trousse pour prépar…ATC—REGISTER NO.FR:60183061PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MERCAPTOACÉTYLTRIGLYCINE
Manufacturer
ROTOP PHARMAKA (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400956689613
    5 flacon(s) en verre - 5 flacon(s) en verre de 2,5 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mercaptoacétyltriglycine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mercaptoacétyltriglycine products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Mertioscan
  • Belgium · Nephromag
  • Germany · Mag-3 Kit
  • Denmark · Nephromag
  • Spain · Nephromag
  • Finland · Nephromag
  • United Kingdom (Northern Ireland) · Ielmag3
  • Ireland · Ielmag3
  • Italy · Mag3
  • Luxembourg · Nephromag
  • Netherlands · Nephromag
  • Norway · Nephromag
  • Portugal · Mertioscan
  • Sweden · Nephromag

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f0551d07-c6c3-4d10-b4c7-03d8e113eb3f
GET /v1/drugs/f0551d07-c6c3-4d10-b4c7-03d8e113eb3f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60183061",
  "date_amm": "2006-09-20",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "MERCAPTOACÉTYLTRIGLYCINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "trousse et  trousse pour préparation radiopharmaceutique pour injection",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about mercaptoacétyltriglycine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.